Perrigo Reaches New 52-Week High (PRGO)
NEW YORK (
) --
(NYSE:
) hit a new 52-week high Friday as it is currently trading at $123.50, above its previous 52-week high of $122.55 with 486,299 shares traded as of 2:15 p.m. ET. Average volume has been 607,300 shares over the past 30 days.
Perrigo has a market cap of $11.47 billion and is part of the health care sector and drugs industry. Shares are up 17.4% year to date as of the close of trading on Wednesday.
Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API) worldwide.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates
Perrigo
as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full
.
See all
52-week high stocks
or get investment ideas from our
.
.
null